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Background: Prenatal drinking water exposure to tetrachloroethylene (PCE) has been previously related to
intrauterine growth restriction and stillbirth. Pathophysiologic and epidemiologic evidence linking these outcomes
to certain other pregnancy complications, including placental abruption, preeclampsia, and small-for-gestational-age
(SGA) (i.e., ischemic placental diseases), suggests that PCE exposure may also be associated with these events. We
examined whether prenatal exposure to PCE-contaminated drinking water was associated with overall or individual
ischemic placental diseases.
Methods: Using a retrospective cohort design, we compared 1,091 PCE-exposed and 1,019 unexposed pregnancies
from 1,766 Cape Cod, Massachusetts women. Exposure between 1969 and 1990 was estimated using water
distribution system modeling software. Data on birth weight and gestational age were obtained from birth
certificates; mothers self-reported pregnancy complications.
Results: Of 2,110 eligible pregnancies, 9% (N = 196) were complicated by ≥1 ischemic placental disease. PCE
exposure was not associated with overall ischemic placental disease (for PCE ≥ sample median vs. no exposure,
risk ratio (RR): 0.90; 95% confidence interval (CI): 0.65, 1.24), preeclampsia (RR: 0.36; 95% CI: 0.12-1.07), or SGA
(RR: 0.98; 95% CI: 0.66-1.45). However, pregnancies with PCE exposure ≥ the sample median had 2.38-times the
risk of stillbirth ≥27 weeks gestation (95% CI: 1.01, 5.59), and 1.35-times of the risk of placental abruption
(95% CI: 0.68, 2.67) relative to unexposed pregnancies.
Conclusions: Prenatal PCE exposure was not associated with overall ischemic placental disease, but may increase
risk of stillbirth.
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Stillbirth, TetrachloroethyleneBackground
In New England between the late 1960’s and early 1980’s,
drinking water exposure to PCE (perchloroethylene or
tetrachloroethylene) was relatively common as the result
of the installation of vinyl-lined asbestos cement (VL/AC)
pipes within public water systems. The vinyl lining, a
slurry of PCE and vinyl toluene resin (Piccotex; Johns-
Manville Corporation, Denver, CO), was introduced as a
solution to taste and odor problems found in existing* Correspondence: aaschen@bu.edu
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unless otherwise stated.pipes. PCE was expected to evaporate by the time of pipe
installation; however, testing in 1980 revealed that large
quantities of PCE remained in public drinking water sup-
plied by VL/AC pipes. Although this specific source of
contamination has since been remediated by bleeding and
flushing VL/AC pipes, adverse health consequences have
also been attributed to public water sources contaminated
by PCE from landfills and underground storage tanks [1],
industrial waste disposal sites [2,3], and dry cleaning faci-
lities [4]. Thus, community-based PCE exposure remains
an important topic of continued investigation.
Prenatal drinking water exposure to PCE has been pre-
viously linked to stillbirth [2] and intrauterine growthLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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including placental abruption and preeclampsia, appears
warranted. These four outcomes, sometimes termed is-
chemic placental diseases or placental dysfunction disor-
ders [5-7], represent a heterogeneous group of disorders
affecting placental function and fetal growth which are
thought to have a common etiologic pathway at the level
of placental vascular development [8]. Ischemic placental
diseases may also share common risk factors [9-13],
making knowledge of risk factors for one ischemic pla-
cental disease potentially informative for identifying
novel risk factors for related disorders.
Based on this, we examined the association between
prenatal PCE exposure and ischemic placental disease in a
population-based retrospective cohort of 1,766 women.Methods
Study population and follow-up
The Cape Cod Family Health Study is a population-based
retrospective cohort study initiated to examine the in-
fluence of prenatal exposure to PCE-contaminated drink-
ing water on multiple outcomes during pregnancy and
childhood [14-16]. The study was approved by the Institu-
tional Review Boards of the Massachusetts Department of
Public Health, Boston University Medical Center, and the
24A/B/11B Review Committee at the Massachusetts
Department of Public Health.
Women were considered eligible for the parent cohort
if they gave birth to at least one child (identified here as
“index” pregnancies or children) between 1969 and 1983
and were living in one of eight Cape Cod towns with
some documented VL/AC water distribution pipes at
the time of the child’s birth. Eligibility was determined
by cross-matching the maternal address on the birth cer-
tificate with water distribution system data obtained
from local water department records. For the initial ex-
posure assessment, we classified women as “exposed” or
“unexposed” at the time of the index child’s birth based
on visual inspection of pipe distribution maps in the
vicinity of the maternal address on the birth certificate.
We considered 1,492 women to be exposed at the time
of the index child’s birth because their residence was
either a) adjacent to a VL/AC pipe or b) adjacent to a
non-VL/AC pipe connected to a VL/AC pipe and this
was the only possible water flow to the residence. From
the remaining eligible women, we selected a comparison
group of 1,704 unexposed women frequency matched to
exposed women based on the birth month and year of
the index child. Initial exposure status was considered
preliminary, and final exposure classification incor-
porated more detailed exposure assessment, as des-
cribed below, and was performed with respect to each
pregnancy.Between 2002 and 2003, we attempted to obtain the
current address and telephone number for eligible mo-
thers, or fathers, if the mother was deceased. Introduc-
tory letters and self-administered questionnaires were
sent to all traced participants. If a participant failed to
respond to our initial contact, we made two additional
attempts to reach them by mail, and if that was also
unsuccessful, we attempted to contact them by phone.
Similar response rates were observed for women ini-
tially classified as exposed and unexposed (Table 1). Par-
ticipants and non-participants were similar with respect
to race and birth year of the index child; however, non-
participating women were younger, less educated, and
had more prior births than participating women. The
gestational duration of index pregnancies was similar,
but non-participating women gave birth to somewhat
lighter infants than participating women. Notably, these
differences were observed for both exposed and unex-
posed participants [14,15].
PCE exposure assessment
We assigned each woman an initial exposure classifica-
tion based on a visual inspection of the proximity of her
residence to VL/AC pipes, as described above. Later, we
refined our approach using the Webler and Brown
leaching and transport model [17] to estimate the mass
of PCE that was delivered to each residence of interest,
from which we calculated a woman’s PCE exposure be-
fore and during each pregnancy. This model uses data
on specific pipe characteristics to estimate the quantity
of PCE entering the drinking water. Specific variables
include the initial PCE loading in the pipe liner, esti-
mated using pipe dimensions; the age of the pipe; and
the leaching rate of PCE from the liner into the drinking
water [18]. The model also requires data on water flow
and direction estimated using the configuration of the dis-
tribution system and the number of water users. For this,
we incorporated the Weber and Brown algorithm into
EPANET water distribution system modeling software
(www.epa.gov/nrml/wswrd/dw/epanet.html), which was
developed by the U.S. Environmental Protection Agency
and has been used to estimate exposure to drinking water
contaminants in multiple epidemiologic studies (e.g., [19]).
As part of the self-administered questionnaire, women
reported the calendar year of occupancy, exact street ad-
dress and nearest cross street, and drinking water source
for each of their family’s Cape Cod residences between
1969 and 1990. Each reported residence was incorpo-
rated into a geographic information system (GIS) using
ArcGIS 8.1 (ESRI, Redlands, CA). Geocoding was con-
ducted without knowledge of exposure status or preg-
nancy history. The majority of the 5,324 total reported
addresses were successfully geocoded to a parcel of land
(87.6%), or, in instances in which the street number was
Table 1 Selection and enrollment status of Cape Cod, Massachusetts women contributing at least one index
pregnancy, by initial exposure status [N (%)]
Initial exposure statusa
Exposedb Unexposedc Total
Selected 1,492 1,704 3,196
Excluded during enrollment
Never located 132 (8.8) 136 (8.0) 268 (8.4)
No response 245 (16.4) 336 (19.7) 581 (18.2)
Ineligible 7 (0.5) 8 (0.5) 15 (0.5)
Refusal 149 (10.0) 137 (8.0) 286 (8.9)
Returned questionnaire
Percent of located 959 (70.5) 1,087 (69.3) 2,046 (69.9)
Percent of selected 959 (64.3) 1,087 (63.8) 2,046 (64.0)
Excluded during exposure assessment and analysis
Incalculable exposure—insufficient data for geocoding residential address 60 (6.3) 75 (6.9) 135 (6.6)
Incalculable exposure-missing data on LMP 20 (2.1) 21 (1.9) 41 (2.0)
Multiple birth 11 (1.2) 21 (1.9) 32 (1.6)
Birth anomaly 22 (2.3) 32 (2.9) 54 (2.6)
Missing data on key covariates 9 (0.9) 9 (0.8)d 18 (0.9)
Final sample 834 932 1,766
Abbreviation: LMP last menstrual period.
aThe exposure status of each pregnancy was assessed later (see Methods).
bContributed ≥1 exposed index births.
cContributed no exposed index births.
dOne woman contributed a stillbirth only to the final analyses.
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of the street (9.6%). Pregnancies associated with the
remaining 2.7% of addresses that were unable to be geo-
coded were excluded from analyses. We assumed that all
land parcels represented water users, all water users in
the network drew the same quantity of water, and water
sources did not change over the study period. These as-
sumptions are supported by observations that the study
area was mainly comprised of residences, and the distri-
bution system changed little between the late 1960s and
late 1980s, when some water sources were added to
accommodate population growth. In addition to the geo-
coded residences, the GIS schematic depicted nodes, or
points of water consumption, and pipe characteristics,
which we inputted using data on the location, installation
date, and diameter of VL/AC pipes obtained from local
water companies and the Massachusetts Department of
Environmental Protection (DEP; Boston, Massachusetts).
The GIS represented the pipe configuration present
around 1980. Lastly, each residence was assigned to the
closest node on the water distribution system. We con-
sidered residences served by a private well or located in
Cape Cod towns with no VL/AC pipes to have no PCE ex-
posure during the study period.
For each pregnancy of interest, we estimated two mea-
sures of PCE exposure: cumulative exposure beforepregnancy and average monthly exposure around the time
of conception. We estimated cumulative exposure before
pregnancy by summing the annual mass of PCE (g) for
each residence between the move-in year or VL/AC pipe
installation year, whichever came later, and the month and
year of the last menstrual period (LMP). Because we did
not have data on the month of move-in or VL/AC pipe
installation, we estimated the annual PCE exposure or, for
exposure occurring only a portion of the year, took a sim-
ple percentage of the annual exposure. We estimated the
average monthly exposure during the LMP year by di-
viding annual exposure during the LMP year by 12. We
estimated the LMP using data from birth certificates or
questionnaires. The LMP and first trimester occurred in
the same year for the majority of pregnancies (85%). In
instances in which this was not the case, misclassification
was likely modest as annual exposure levels between the
LMP and first-trimester years were highly correlated
(Pearson correlation coefficient = 0.96; P < 0.0001).
Both exposure metrics represent the estimated mass of
PCE delivered to a residence during a specific time
period, only a small portion of which was actually con-
sumed by study participants. After taking into account
dilution in the estimated 90,000 gallons of water used
annually by an average Massachusetts household [20],
we converted the estimated PCE mass delivered to a
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These values were consistent with actual water-sampling
data from that time period [18].
Assessment of ischemic placental disease
Between 2002–2003, we used birth certificates and ques-
tionnaires completed by the women to obtain data on
pregnancies occurring between 1969 and 1983 in any of
the eight Cape Cod towns of interest (i.e., “index” preg-
nancies). Data on all other pregnancies contributed by
these women (i.e., “non-index” pregnancies) were obtained
from the questionnaire only. Thus, women could contri-
bute only index pregnancies or both index and non-index
pregnancies. Women reported whether each pregnancy
ended in a live birth, stillbirth, miscarriage, abortion
(induced or therapeutic), or ectopic pregnancy, as well as
the date that the pregnancy ended, and the approximate
length of the pregnancy. Women also reported whether
pregnancies were complicated by placental abruption or
separation, preeclampsia, or vaginal bleeding. The gesta-
tional age at which any complications occurred was not
obtained. Data on birth weight was obtained from birth
certificates to limit misclassification. We investigated the
following individual ischemic placental diseases: placental
abruption, preeclampsia, small for gestational age (SGA)
infant (birth weight <10th percentile of a gestational age-
and sex-specific birth weight distribution for singleton
births) [21], and stillbirth. We also investigated vaginal
bleeding at any gestational age, which has a more hetero-
geneous etiology, but may be linked to placental dys-
function. Finally, we constructed a composite outcome of
overall ischemic placental disease, which included preg-
nancies with ≥1 of the following: placental abruption, pre-
eclampsia, an SGA infant, or stillbirth.
Of 6,519 total pregnancies, we excluded pregnancies
with an unknown outcome (N = 14), ectopic pregnancies
(N = 49), and abortions (N = 367). We additionally ex-
cluded pregnancies with incalculable exposure status
due to missing data on LMP (N = 178) or insufficient
residential data for accurate geocoding and exposure as-
sessment (N = 344), as well as losses <27 weeks gestation
(N = 623) and multiple births (N = 72). After further re-
striction to pregnancies without missing data on key co-
variates, 4,760 pregnancies were eligible for individual
analyses of placental abruption, and 4,836 pregnancies
(4,809 live births and 27 stillbirths) were eligible for ana-
lyses of preeclampsia and stillbirth. An eligibility flow-
chart shows this in more detail (see Additional file 1).
We obtained data on birth weight and gestational du-
ration from birth certificates, which were only available
for index children; thus, for analyses of the composite
outcome, we further restricted the study population to
2,110 pregnancies (2,084 index live births and 26 still-
births) with no reported birth anomalies (excluding2,542 non-index births, 171 babies with birth anomalies,
and 13 observations missing data on key covariates). Of
these, only live births were considered eligible for indi-
vidual analyses of SGA (N = 2,002 after further exclusion
of 82 with missing data on covariates).
Assessment of covariate data
Data on the parents’ ages and educational levels were
obtained from the birth certificate for index children,
and from the self-administered questionnaire for non-
index children. Other data on parental demographics
and reproductive characteristics were also obtained from
the questionnaire.
Statistical analysis
We calculated risk ratios (RR) and 95% confidence inter-
vals (CI) for the association between prenatal PCE expo-
sure and ischemic placental disease using log-binomial
regression. To account for the non-independence of preg-
nancies contributed by the same woman, we used gene-
ralized estimating equations (GEE) [22,23], for which we
assumed constant correlation between pregnancies con-
tributed by the same mother. For our primary approach,
we compared pregnancies with PCE exposure ≥ the sam-
ple median or < the sample median to those with no ex-
posure, which was considered the reference group. We
also compared pregnancies with any PCE exposure to
those with no exposure. For analyses of the composite
outcome, we examined PCE exposure in two additional
ways: 1) to investigate the dose–response of the asso-
ciation, we categorized PCE exposure into quartiles and
compared pregnancies in each quartile of exposure to the
reference group of no exposure, and 2) we classified ex-
posed pregnancies with respect to levels corresponding to
the 1980 action level of 40 ppb (1.136 g) which prompted
environmental remediation [18] and compared each of
these groups (≥40 ppb and <40 ppb) to unexposed preg-
nancies. Small sample size precluded us from utilizing
these additional exposure metrics for analyses of indivi-
dual ischemic placental diseases.
We conducted multivariable analyses adjusting for pre-
viously identified risk factors for individual ischemic pla-
cental diseases. Women with previous ischemic placental
disease are at an increased risk of developing ischemic pla-
cental disease during subsequent pregnancies [5,24-27];
thus, whenever possible, we adjusted for the potentially
important confounder of prior ischemic placental disease.
Models for placental abruption were adjusted for hy-
pertension before or during pregnancy (yes, no) and
first-trimester smoking (none, <11 cigarettes/day, ≥11
cigarettes/day) [28]; models for preeclampsia were ad-
justed for first-trimester smoking and combined parity
and prior ischemic placental disease (nulliparous, ≥1 prior
pregnancy with no prior ischemic placental disease, ≥1
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[29]; models for SGA were adjusted for maternal age
(<25 y, 25–29.9 y, 30–34.9 y, ≥35 y), year that the preg-
nancy ended (<1974, 1975–1980, and >1980), gestational
weight gain <20 lb (yes, no), hypertension before or during
pregnancy, combined parity and prior ischemic placental
disease, and first-trimester smoking [30-32]; models for
stillbirth were adjusted for first-trimester smoking [33];
and models for vaginal bleeding were adjusted for mater-
nal age and combined parity and prior ischemic placental
disease [34,35]. Based on this, we adjusted models for
overall ischemic placental disease for the year that the
pregnancy ended, maternal age, and combined parity and
prior ischemic placental disease. When we individually
added additional covariates, including first-trimester smo-
king, inadequate weight gain, and hypertension before or
during pregnancy, to the model, none were found to have
a meaningful impact on observed effect estimates.
As a sensitivity analysis, we examined associations of
prenatal PCE with placental abruption, preeclampsia,
and stillbirth in the restricted sample used for the com-
posite outcome (e.g., only index live births and losses).
We investigated whether associations varied by maternal
age, prior ischemic placental disease, year of pregnancy,
or first trimester cigarette smoking or alcohol use.
Results
A total of 2,110 pregnancies, including 2,084 live index
births for whom we obtained birth certificate data and 26
stillbirths (≥27 weeks gestation), were considered eligible
for analyses of the composite outcome. This included
pregnancies from 1,766 women, 300 (17%) of whom con-
tributed 2 pregnancies, and 44 (2%) of whom contributed
≥3 pregnancies. We classified 196 (9%) of these pregnan-
cies as having at least one ischemic placental disease, with
SGA the most commonly identified disorder (N = 133; 6%
of live births). Placental abruption (N = 20), preeclampsia
(N = 25), and stillbirth at ≥27 weeks gestation (N = 26)
were each identified in approximately 1% of eligible preg-
nancies. The majority of affected pregnancies were cha-
racterized by a single disorder (96%); 8 pregnancies were
complicated by ≥1 disorder. Approximately 6% of live
births complicated by ischemic placental disease resulted
in a preterm birth (N = 10).
Many parental characteristics, including maternal age,
race, and education, were similarly distributed across
PCE-exposed and unexposed pregnancies (Table 2). How-
ever, certain groups, including parous women and women
whose spouses were employed in a white-collar occupa-
tion, were more likely to have an exposed pregnancy.
Average monthly PCE exposure during the LMP year
ranged from 0 to 89.2 g, with a median of 0.9 g among
exposed pregnancies (Table 3). Cumulative PCE expo-
sure before the LMP month and year ranged from 0 to3,600 g, with a median of 28.9 g among exposed preg-
nancies. The two measures were highly correlated, with
a Spearman correlation coefficient of 0.88 (P < 0.001).
We did not observe an association between average
monthly PCE exposure during the LMP year and report
of at least one ischemic placental disease, holding cova-
riates constant (for PCE ≥ the sample median vs. 0, RR:
0.90; 95% CI: 0.65, 1.24) (Table 4). Alternative classifica-
tion of average monthly PCE exposure during the LMP
year using quartiles or with respect to the 1980 action
level of 40 ppb yielded similar findings.
Next, we examined associations of average monthly
PCE exposure during the LMP year and individual ische-
mic placental diseases. In a sample including both index
and non-index pregnancies, we observed 46 cases of pla-
cental abruption (1%), 49 cases of preeclampsia (1%),
and 27 stillbirths (1%). Vaginal bleeding was present in
7% of pregnancies (N = 326). One-half of pregnancies
(N = 23) complicated by placental abruption ended in a
preterm birth, as did 12% (N = 6) of preeclampsia cases
and 2% (N = 3) of pregnancies that resulted in an SGA
infant.
Pregnancies with PCE exposure greater than or equal
to the sample median had 2.38-times the risk of ending
in stillbirth relative to those with no exposure, holding
covariates constant (95% CI: 1.01, 5.59) (Table 5). Preg-
nancies with the greatest exposure also had a 35% in-
creased risk of placental abruption (95% CI: −32%,
167%) relative to unexposed pregnancies. After restric-
ting to index live births and losses (i.e., the same sample
used for analyses of overall ischemic placental disease),
pregnancies with prenatal PCE exposure were no more
likely to end in placental abruption or stillbirth than un-
exposed pregnancies (data not shown). Prenatal PCE ex-
posure was not associated with preeclampsia or delivery
of an SGA infant. We observed an elevated risk of va-
ginal bleeding in pregnancies with PCE exposure greater
than or equal to the sample median (RR: 1.58; 95% CI:
1.23, 2.02).
Similar effect estimates for overall and individual is-
chemic placental diseases were obtained when PCE was
alternatively modeled as cumulative exposure occurring
before the LMP month and year (data not shown). Re-
sults were not modified by maternal age, prior ischemic
placental disease, year of pregnancy, cigarette smoking,
or alcohol use during the first trimester.
Discussion
Our results suggest that prenatal PCE exposure is not
associated with overall ischemic placental disease, but
may increase the risk of individual obstetric complica-
tions, including stillbirth and placental abruption. This
discrepancy between a null overall association despite
several positive associations for individual disorders
Table 2 Characteristics of 2,110 index pregnancies, by PCE exposure during the LMP year and occurrence of ischemic
placental diseasea










Before 1974 15.2 21.2 15.7 18.3
1975-1980 51.1 44.2 49.8 49.4
After 1980 33.7 34.6 34.5 32.4
Maternal age (y)c, mean (SD) 26.2 (4.3) 26.6 (4.4) 27.5 (4.5) 27.0 (4.6)
Paternal age (y), mean (SD) 29.5 (5.8) 29.5 (5.5) 30.7 (5.6) 29.9 (5.6)
White 91.3 95.2 95.7 97.4
Maternal educationb
Less than high school 3.3 1.9 1.1 1.1
High school graduate 22.8 25.0 19.2 18.4
Some college 32.6 35.6 33.9 34.8
Four-year college graduate or more 41.3 37.5 45.8 45.8
Paternal occupationb
White collar 40.2 39.4 53.7 46.0
Blue collar 34.8 42.3 31.6 32.0
Other 21.7 15.4 13.2 20.4
Number of prior livebirths and prior ischemic placental diseaseb
Nulliparous 43.5 58.7 35.5 41.0
Previous pregnancy, no prior ischemic placental disease 45.7 35.6 60.1 56.7
Previous pregnancy, prior ischemic placental disease 10.9 5.8 4.4 2.3
Diabetes before or during pregnancy 1.1 4.8 2.3 2.2
Hypertension before or during pregnancy 10.9 18.3 5.2 5.8
Gestational weight gain <20 lb 30.4 21.2 13.8 12.4
Cigarette smoking during first trimester 41.3 36.5 24.8 27.2
Alcohol consumption during first trimester 32.6 40.4 37.2 37.6
Occupational exposure to solventsb
No 76.1 86.5 86.3 87.2
Yes, before or during pregnancy 17.4 11.5 10.9 9.8
Yes, unknown when 2.2 1.0 1.7 1.3
Use of solvent-based spot removers 63.0 57.7 67.3 64.0
Use of professional dry cleaning 82.6 86.5 87.7 85.8
Use of self-service dry cleaning 21.7 13.5 13.8 16.7
Abbreviations: LMP last menstrual period, PCE tetrachloroethylene, SD standard deviation.
aIncluding placental abruption, preeclampsia, small for gestational age, and stillbirth at ≥27 weeks gestation.
bPercentages do not sum to 100 due to rounding or missing values.
cMissing: paternal age (N = 18), paternal occupation (N = 35), diabetes (N = 20), hypertension (N = 23), gestational weight gain <20 lb (N = 62), alcohol consumption
(N = 4), occupational exposure to solvents (N = 31), use of spot removers (N = 40), use professional dry cleaning (N = 79), use of self-service dry cleaning (N = 56).
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analyses. Specifically, prenatal PCE was associated with
placental abruption and stillbirth in the full sample of
index and non-index pregnancies, but not the smaller
sample of pregnancies used for analyses of the compos-
ite outcome. We attribute this inconsistency to the small
number of exposed cases in the restricted sample rathera systematic difference between the two samples, which
came from the same group of mothers.
Of four previous community-based studies relating
exposure to PCE-contaminated drinking water to preg-
nancy loss, only one has reported positive findings. No
association was reported in a cross-sectional study of
town-level PCE or trichloroethylene (TCE) exposure and
Table 3 Distribution of cumulative PCE exposure before
LMP and average monthly PCE exposure during LMP year







LMP month and year
(N = 1,091).a
Minimum 2.8 × 10−4 1.2 × 10−4
5th percentile 3.4 × 10−1 1.7 × 10−2
10th percentile 1.0 4.0 × 10−2
Median 28.9 0.9
75th percentile 117.2 2.9
90th percentile 333.4 7.7
Maximum 3,600 89.2
Abbreviations: LMP last menstrual period, PCE tetrachloroethylene.
aThere were 1,091 pregnancies that were exposed both before and during the
LMP year. All pregnancies exposed during the LMP year were also exposed
before the LMP year, but 97 pregnancies exposed before the LMP year were
unexposed during the LMP year. Thus, average monthly exposure during the
LMP year includes 1,188 exposed pregnancies (1,091 + 97).
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women [1], or in a previous publication from this cohort
examining associations of prenatal PCE exposure with
overall pregnancy loss, first-trimester loss, and combined
second- and third-trimester loss [15]. In a study of
Woburn, MA residents, women exposed to well water
contaminated with PCE, TCE, and other chlorinatedTable 4 Risk ratios and 95% confidence intervals for the asso
during the LMP year and overall ischemic placental diseasea
Events/N R
Exposure categorized by any or the sample median
Any exposure 92/1,091 0
≥50th (5.7 × 10−1 g - 89.2 g) 55/635 0
>0- < 50th (1.2 × 10−4 g – 5.7 × 10−1 g) 37/456 0
0 104/1,019 1
Exposure categorized by 1980 action level (40 ppb)
≥1.136 g (40 ppb) 39/480 0
>0 - <1.136 g 53/611 0
0 104/1,019 1
Exposure categorized in quartiles (percentiles)
≥75th (2.3 g - 89.2 g) 26/331 0
50th-75th (5.7 × 10−1 g - 2.3 g) 29/304 0
25th-50th (1.3 × 10−1 g - 5.7 × 10−1 g) 20/261 0
>0- < 25th (1.2 × 10−4 g – 1.3 × 10−1 g) 17/195 0
0 104/1,019 1
Abbreviations: CI confidence interval, GEE generalized estimating equation, LMP last
aIncluding placental abruption, preeclampsia, small for gestational age, and stillbirth
bAdjusted for maternal age during LMP year (<25 y, 25–29.9 y, 30–34.9 y, 35+ y), ye
disease (nulliparous, parous without history of ischemic placental disease, parous w
(none, <11 cigarettes/day, ≥11 cigarettes/day).organic chemicals were not found to be at an increased
risk of pregnancy loss [3]. However, when this analysis
was repeated using a more sensitive model of the water
distribution system and with data on fetal deaths ob-
tained from the Massachusetts Registry of Vital Records
(losses ≥20 weeks or fetuses weighing ≥350 g) rather
than self-reported by the participants, women with the
greatest exposure had 2.6-times the risk of stillbirth
(95% CI: 0.7, 8.9) as unexposed women [2].
Prenatal PCE exposure has been more consistently
associated with measures of intrauterine growth restric-
tion. In a retrospective cohort study of Camp Lejeune
residents, infants born to PCE-exposed women had a
modest elevation in risk of SGA (odds ratio: 1.2, 90% CI:
1.0, 1.3) relative to those of unexposed women, with
stronger associations observed in certain vulnerable po-
pulations, including women ≥35 years and women with
two or more prior losses [4]. Similarly, Endicott, New
York women exposed to TCE, but not PCE, in indoor
air had 1.2-times the risk (95% CI: 1.0, 1.5) of delivering
an SGA infant compared to women from the rest of the
state [36]. PCE has been associated with low birth
weight (<2,500 g) and very low birth weight (<1,500 g)
in some [1,37], but not all [1,3,4,14,37], studies. To our
knowledge, studies of prenatal PCE with placental
abruption and preeclampsia have not been previously
undertaken.ciation between average monthly PCE exposure (g)
among 2,110 index pregnancies
Model 1: Unadjusted GEE Model 2: Multivariable GEEb
R 95% CI RR 95% CI
.81 0.61, 1.07 0.86 0.65, 1.14
.82 0.59, 1.14 0.90 0.65, 1.24
.79 0.54, 1.15 0.82 0.55, 1.23
.00 Referent 1.00 Referent
.77 0.54, 1.11 0.88 0.62, 1.26
.83 0.60, 1.16 0.85 0.61, 1.20
.00 Referent 1.00 Referent
.77 0.50, 1.17 0.87 0.56, 1.35
.88 0.57, 1.35 0.91 0.60, 1.39
.72 0.44, 1.18 0.74 0.43, 1.26
.89 0.54, 1.46 0.95 0.58, 1.54
.00 Referent 1.00 Referent
menstrual period, PCE tetrachloroethylene, RR risk ratio.
at ≥27 weeks gestation.
ar pregnancy ended (<1974, 1975–1980, and >1980), prior ischemic placental
ith history of ischemic placental disease), and first-trimester smoking
Table 5 Risk ratios and 95% confidence intervals for associations between average monthly PCE exposure (g) during
the LMP year (percentiles) and individual ischemic placental diseases
Model 1: Unadjusted GEE Model 2: Multivariable GEEa
Events/N RR 95% CI RR 95% CI
Placental abruptionb
Any 18/1,698 1.13 0.63, 2.04 1.19 0.65, 2.15
≥50th (5.7 × 10−1 g – 132 g) 11/846 1.36 0.69, 2.70 1.35 0.68, 2.67
>0- < 50th (9.6 × 10−5 g – 5.7 × 10−1 g) 7/852 0.90 0.41, 1.97 0.90 0.41, 1.97
0 28/3,062 1.00 Referent 1.00 Referent
Preeclampsiab
Any 8/1,721 0.35 0.16, 0.76 0.37 0.17, 0.83
≥50th (5.7 × 10−1 g – 132 g) 4/859 0.34 0.12, 0.97 0.36 0.12, 1.07
>0- < 50th (9.6 × 10−5 g – 5.7 × 10−1 g) 4/862 0.37 0.14, 0.99 0.39 0.14, 1.10
0 41/3,115 1.00 Referent 1.00 Referent
SGAc
Any 68/1,034 0.97 0.69, 1.35 1.04 0.75, 1.46
≥50th (5.7 × 10−1 g – 89.2 g) 38/600 0.91 0.61, 1.36 0.98 0.66, 1.45
>0- < 50th (1.2 × 10−4 g – 5.7 × 10−1 g) 30/434 1.05 0.68, 1.61 1.15 0.75, 1.76
0 62/968 1.00 Referent 1.00 Referent
Stillbirthb, d
Any 13/1,721 1.69 0.77, 3.68 1.67 0.76, 3.67
≥50th (5.7 × 10−1 g – 132 g) 9/859 2.39 1.02, 5.61 2.38 1.01, 5.59
>0- < 50th (9.6 × 10−5 g – 5.7 × 10−1 g) 4/862 0.99 0.31, 3.17 0.98 0.30, 3.14
0 14/3,115 1.00 Referent 1.00 Referent
Abbreviations: CI confidence interval, GEE generalized estimating equation, LMP last menstrual period, PCE tetrachloroethylene, RR risk ratio, SGA small for
gestational age.
aModel for placental abruption adjusted for hypertension before or during pregnancy (yes, no) and first-trimester smoking (none, <11 cigarettes/day, ≥11
cigarettes/day). Model for preeclampsia adjusted for smoking and combined parity and previous ischemic placental disease (nulliparous, parous with no previous
ischemic placental disease, parous with previous ischemic placental disease). Model for SGA adjusted for maternal age during LMP year (<25 y, 25–29.9 y,
30–34.9 y, 35+ y), year pregnancy ended (<1974, 1975–1980, and >1980), gestational weight gain <20 lb, hypertension before or during pregnancy, first-trimester
smoking, and combined parity and previous ischemic placental disease. Model for stillbirth adjusted for first-trimester smoking.
bAll live births and stillbirths ≥27 weeks gestation with non-missing data on covariates.
cIndex live births with non-missing data on covariates.
dStillbirth ≥27 weeks gestation.
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http://www.ehjournal.net/content/13/1/72PCE exposure assessment was conducted without
knowledge of pregnancy complications, making differen-
tial exposure misclassification unlikely. Sources of non-
differential exposure misclassification include use of 1980
water distribution system conditions to characterize the
entire study period and our inability to incorporate indi-
vidual-level data on water consumption and bathing
habits, which were poorly recalled. Despite this, validation
studies indicate good correlation of historical PCE
sampling with exposure estimates from the original
Webler-Brown flow algorithm [38] and the EPANET
water distribution system modeling software [39]. Expo-
sure at different time points in gestation may contribute
to the exact phenotype observed; however, we were unable
to characterize trimester-specific exposure.
SGA was calculated using data from birth certificates,
and is therefore unlikely be to misclassified. Women
were asked to recall their pregnancies over a period of19 to 34 years, and may have over- or under-reported
placental abruption, preeclampsia, and stillbirth. Pre-
vious validation studies suggest moderate to good ma-
ternal recall of pregnancy complications [40,41]. One
validation study of women who gave birth 10–15 years
earlier reported 94.2% and 96.5% agreement between
self-reported preeclampsia and placental abruption with
medical records, respectively [40]. Accuracy of recall
over longer periods appears similarly acceptable, with
Rochester, Minnesota women reporting a previous diag-
nosis of preeclampsia or eclampsia with 80% sensitivity
and 96% specificity over 20 years later [41]. The relia-
bility of women in our cohort is further supported by
our finding of good to excellent agreement between
questionnaire and birth certificate data for select va-
riables, including birth weight and parity [15]. Any
misclassification of pregnancy complications is unlikely
to be differential with respect to exposure status, as
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http://www.ehjournal.net/content/13/1/72participants were generally unaware of their exposure to
PCE-contaminated drinking water [15].
VL/AC pipes were used to both extend and replace exist-
ing pipes, making their distribution within the water system
fairly irregular. Consequently, the distribution of PCE ex-
posure was observed to be independent from potentially
confounding variables such as age, education, and socio-
economic status. However, we cannot rule out the possibi-
lity that our results may, in part, be explained by residual or
unmeasured confounding. For analyses of stillbirth and pre-
eclampsia, small sample sizes limited the number of cova-
riates we were able to include in adjusted models [42].
Selection bias is unlikely because we were unaware of a
woman’s pregnancy complications when deciding her eli-
gibility status, and women who chose not to participate
were demographically similar to women who enrolled in
the study. We investigated pregnancy complications oc-
curring at 27 weeks gestation or later, and it is possible
that a differential loss of pregnancies before this point
may have led us to underestimate the true effect size. Spe-
cifically, such a ‘competing mortality’ bias could exist if
the pregnancies most susceptible to PCE-induced compli-
cations of late pregnancy were not included in our analysis
because they were also more likely to be spontaneously
aborted in the 1st or 2nd trimester [43]. Previous findings
from this cohort, however, suggest that prenatal PCE ex-
posure is not associated with early pregnancy loss [15].
Ischemic placental diseases occurring <37 weeks gesta-
tion may have a different etiology than those occurring at
term. For instance, early onset preeclampsia is thought to
be more strongly associated with partial or absent spiral
artery remodeling relative to disease occurring at term
[44,45], and prior preterm preeclampsia is more strongly
associated with future risk of an ischemic placental disease
than previous term preeclampsia [27,46]. Similar findings
have been reported for placental abruption [47]. Although
we might therefore expect a stronger association of prenatal
PCE exposure with preterm, rather than overall, ischemic
placental disease, the small number of preterm births in
our cohort precluded us from pursuing this hypothesis. We
reported elevated risk ratios for vaginal bleeding at any time
during pregnancy. Due to the etiologic heterogeneity of this
outcome, we are unable to determine whether bleeding was
a marker of placental dysfunction.
Conclusions
We did not detect an association between prenatal PCE
exposure and overall ischemic placental disease. When
pregnancy complications were assessed individually, we ob-
served modestly elevated risk ratios for vaginal bleeding,
and, in certain samples, stillbirth and placental abruption.
Future investigation of drinking-water contamination and
ischemic placental disease is necessary, as drinking water
contamination remains common [48,49].Additional file
Additional file 1: Eligibility flowchart. Flowchart showing eligibility
criteria and Ns specific to each analysis.
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